24 May 2013
Keywords: positive, ph, ii, results, adolar, entereg, adolor
Article | 19 January 2004
Adolor Corp of the USA says that top-line results of a Phase III study of Entereg (alvimopan), licensed to GlaxoSmithKline, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 January 2004
23 May 2013
© 2013 thepharmaletter.com